CD274 and non-small cell lung carcinoma: A review of the literature published through 2019 investigated the role of tobacco smoking in immunotherapy targeting PD-1/PD-L1 by summarizing the findings of clinical trials and reached the conclusion that NSCLC in current/former smokers responded better than that in non-smokers to immunotherapies (11).